Growth funding Vital has secured substantial funding rounds including a $24.7M Series B and earlier $15M in Series A, signaling strong investor confidence and a scalable growth trajectory that can support expanded sales outreach to larger hospital systems and health networks.

Expansion momentum Recent headcount growth and expansion in solution offerings (ER, Inpatient, Access) indicate a growing customer footprint and increasing demand for integration, enabling sales to target health systems seeking comprehensive patient experience platforms.

AI patient experience AI-driven predictions and follow-up adherence capabilities position Vital as a scalable platform to upsell to hospitals aiming to improve patient outcomes, reduce readmissions, and enhance loyalty across ED and inpatient settings.

EHR integration Vital’s HIPAA-compliant cloud-based experience layer that integrates with any electronic health record system creates a low-friction value proposition for health systems with diverse EHR ecosystems, opening opportunities with multi-system networks.

Regulatory alignment Tools like the Lab Results feature aligned with 21st Century Cures Act demonstrate readiness to address regulatory and patient-access requirements, making Vital appealing to health systems pursuing compliance-enabled patient portals and result transparency.